Rapid infectious disease test
COVID-19for antigensprotein

rapid infectious disease test
rapid infectious disease test
Add to favorites
Compare this product


for infectious diseases, COVID-19
Tested parameter
for antigens, protein
Sample type
nasopharyngeal, nasal
Analysis mode
lateral flow


The fluorecare® SARS-CoV-2 Spike Protein Test Kit is applicable to the qualitative detection novel Coronavirus (SARS-CoV-2) Spike Protein in population Oropharyngeal swabs and Nasopharyngeal swabs samples in vitro. The clinical performance of the SARS-CoV-2 Spike Protein Test Kit (Colloidal Gold Chromatographic Immunoassay) was evaluated compared to RT-PCR positive cases. Positive percent agreement is 91.27% and negative percent agreement is 100.00% in theSARS-CoV-2 Spike Protein Test Kit. Our product is registered in Spain, Germany, Italy, Belgium, Switzerland and US EUA under process.



No catalogs are available for this product.

See all of XNY Medical Technology‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.